Contributo scientifico, sviluppato generalmente su uno specifico argomento, che illustra risultati originali di una ricerca o presenta caratteristiche di review, cioè di discussione dello stato dell’arte o della letteratura entro un ambito scientifico definito. La rivista di pubblicazione deve presentare caratteristiche di scientificità. La tipologia non comprende editoriali, commenti brevi, repliche, abstract, errata, recensioni e prodotti similari, per i quali sono previste specifiche tipologie.
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B
2021 Iacovino, L. G.; Pinzi, L.; Facchetti, G.; Bortolini, B.; Christodoulou, M. S.; Binda, C.; Rastelli, G.; Rimoldi, I.; Passarella, D.; Di Paolo, M. L.; Dalla Via, L.
LigAdvisor: A versatile and user-friendly web-platform for drug design
2021 Pinzi, L.; Tinivella, A.; Gagliardelli, L.; Beneventano, D.; Rastelli, G.
Toward Future Automatic Warehouses: An Autonomous Depalletizing System Based on Mobile Manipulation and 3D Perception
2021 Aleotti, Jacopo; Baldassarri, Alberto; Bonfè, Marcello; Carricato, Marco; Chiaravalli, Davide; Di Leva, Roberto; Fantuzzi, Cesare; Farsoni, Saverio; Innero, Gino; Lodi Rizzini, Dario; Melchiorri, Claudio; Monica, Riccardo; Palli, Gianluca; Rizzi, Jacopo; Sabattini, Lorenzo; Sampietro, Gianluca; Zaccaria, Federico
Damage modelling strategies for unidirectional laminates subjected to impact using CZM and orthotropic plasticity law
2021 Goldoni, G.; Mantovani, S.
Use of monoclonal antibody to treat covid-19 in children and adolescents: Risk of abuse of prescription and exacerbation of health inequalities
2021 Esposito, S.; Zona, S.; Pession, A.; Iughetti, L.; Migliori, G. B.; Principi, N.
“WAITING FOR YOUR INFO” An explanatory look at the communicative strategies deployed to mitigate potentially face-threatening acts in emails
2020 Poppi, Franca
OVERVIEWING RESEARCH ON BELF COMMUNICATION STRATEGIES From professional practice to ELT materials
2020 Facchinetti, Roberta; Vettorel, Paola; Poppi, Franca; Franceschi, Valeria; Caleffi, Paola Maria
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation
2021 Costi, S; Tonelli, R; Brogneri, A; Florini, A; Tilocca, N; Vicentini, M; Baroncini, S; Cerulli, M; Clini, E.
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice
2021 Daini, E.; Secco, V.; Liao, W.; Zoli, M.; Vilella, A.
Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior
2021 Detraux, B.; Vilella, A.; De Groote, A.; Schiffmann, S. N.; Zoli, M.; De Kerchove D'Exaerde, A.
Contribution of nicotinic acetylcholine receptors containing the beta 2-subunit to the behavioural effects of nicotine
1997 Picciotto, Mr; Zoli, Michele; Zachariou, V; Changeux, Jp
CHRONIC BUT NOT ACUTE URIDINE TREATMENT REDUCES HALOPERIDOL-INDUCED DOPAMINE RELEASE IN NEOSTRIATUM AS STUDIED BY INTRACEREBRAL MICRODIALYSIS
1990 Ruggeri, M; Zoli, Michele; Ungerstedt, U; Peruzzi, G; Agnati, Luigi Francesco; Fuxe, K.
Morphometrical and microdensitometrical studies on peptide immunoreactivities in methylazoxymethanol prenatal treated rats
1989 Zoli, M.; Cimino, M.; Cattabeni, F.; Agnati, L. F.
“Tiny new ingredients are a big concern”. The popularization of nanotechonologies in environmental organizations’ and institutions’ publications.
2020 Poppi, Franca; Sezzi, Annalisa
INCREASE IN THE DENSITY OF NEUROPEPTIDE-Y IMMUNOREACTIVE CELL-BODIES SELECTIVELY IN THE FUNDUS STRIATI OF RATS PRENATALLY EXPOSED TO METHYLAZOXYMETHANOL ACETATE
1990 Zoli, Michele; Peruzzi, G; Cimino, M.
NEUROPEPTIDES, EXCITATORY AMINO-ACID AND ADENOSINE A2 RECEPTORS REGULATE D2 RECEPTORS VIA INTRAMEMBRANE RECEPTOR-RECEPTOR INTERACTIONS - RELEVANCE FOR PARKINSONS-DISEASE AND SCHIZOPHRENIA
1992 Fuxe, K; Agnati, Luigi Francesco; Voneuler, G; Tanganelli, S; Oconnor, Wt; Ferre, S; Hedlund, P; Zoli, Michele
Central Glucocorticoid Receptor Immunoreactive Neurons: New Insights into the Endocrine Regulation of the Brain
1987 Fuxe, K.; Cintra, A.; Harfstrand, A.; Agnati, L. F.; Kalia, M.; Zoli, M.; Wikstrom, A. -C.; Okret, S.; Aronsson, M.; Gustafsson, J. -A.
ON THE ROLE OF NEUROPEPTIDE Y IN INFORMATION HANDLING IN THE CENTRAL-NERVOUS-SYSTEM IN NORMAL AND PHYSIOPATHOLOGICAL STATES - FOCUS ON VOLUME TRANSMISSION AND NEUROPEPTIDE Y DELTA-2 RECEPTOR INTERACTIONS
1990 Fuxe, K; Agnati, Luigi Francesco; Harfstrand, A; Zoli, Michele; Voneuler, G; Grimaldi, R; Pich, Em; Bjelke, B; Eneroth, P; Benfenati, F; Cintra, A; Zini, Isabella; Martire, M.
Neuropeptide Y (NPY) and adrenaline (A) interactions in the central control of arterial blood pressure (ABP) in the male rat
1993 Agnati, L. F.; Zoli, M.; Aguirre, J. A.; Fuxe, K.; Benfenati, F.
Demonstration of NPY transmitter receptor mismatches in the central nervous system of the male rat
1989 Zoli, M.; Agnati, L. F.; Fuxe, K.; Bjelke, B.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA69878
- Atti di CONVEGNO1
- Contributo su VOLUME1
Data di pubblicazione
- 2020 - 202720216
- 2010 - 201923518
- 2000 - 200914312
- 1990 - 19998031
- 1980 - 19893149
- 1970 - 1979640
- 1966 - 196911
Editore
- Elsevier BV:PO Box 211, 1000 AE A...334
- American Institute of Physics:2 H...226
- Elsevier Science Limited:Oxford F...189
- Giuffre Editore Spa:via Busto Ars...101
- Societa Editrice il Mulino Spa:St...73
- Springer Verlag Germany:Tiergarte...71
- IEEE / Institute of Electrical an...70
- Academic Press Incorporated:6277 ...67
- American Chemical Society:1155 Si...63
- Edizioni Minerva Medica:Corso Bra...59
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS404
- EFSA JOURNAL380
- PLOS ONE315
- PHYSICAL REVIEW LETTERS309
- PHYSICAL REVIEW. B, CONDENSED MAT...294
- SCIENTIFIC REPORTS290
Serie
- EUROPEAN DISTANCE AND E-LEARNING ...1
Keyword
- Humans4564
- Female2680
- Male2251
- Middle Aged1673
- Adult1526
- Aged1328
- Italy767
- Treatment Outcome649
- COVID-19587
- 80 and over506
Lingua
- eng58338
- ita10785
- fre334
- spa300
- ger189
- por61
- rus24
- und23
- chi15
- pol7
Accesso al fulltext
- no fulltext29932
- open19779
- reserved18713
- partially open1440
- embargoed15
- mixed1
